COVID-19 Impact on Global Nerve Biologic Products, Market Insights and Forecast to 2026

BMR3903699
114 Pages
June 2020
Healthcare

Download Sample Get Discount

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Nerve Biologic Products market in 2020.

COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.

The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

This report also analyses the impact of Coronavirus COVID-19 on the Nerve Biologic Products industry.

Based on our recent survey, we have several different scenarios about the Nerve Biologic Products YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Nerve Biologic Products will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Nerve Biologic Products market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Nerve Biologic Products market in terms of both revenue and volume.

Players, stakeholders, and other participants in the global Nerve Biologic Products market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.

Sales and Pricing Analyses

Readers are provided with deeper sales analysis and pricing analysis for the global Nerve Biologic Products market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.

In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.

Regional and Country-level Analysis

The report offers an exhaustive geographical analysis of the global Nerve Biologic Products market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.

Competition Analysis

In the competitive analysis section of the report, leading as well as prominent players of the global Nerve Biologic Products market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Nerve Biologic Products market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Nerve Biologic Products market.

The following manufacturers are covered in this report:

Axogen

Integra

Synovis

Collagen Matrix

Polyganics

Checkpoint Surgical

Neurotex

...

Nerve Biologic Products Breakdown Data by Type

Nerve Conduit

Nerve Wrap

Nerve Graft

Others

Nerve Biologic Products Breakdown Data by Application

Direct Nerve Repair/Neurorrhaphy

Nerve Grafting

1 Study Coverage

1.1 Nerve Biologic Products Product Introduction

1.2 Market Segments

1.3 Key Nerve Biologic Products Manufacturers Covered: Ranking by Revenue

1.4 Market by Type

1.4.1 Global Nerve Biologic Products Market Size Growth Rate by Type

1.4.2 Nerve Conduit

1.4.3 Nerve Wrap

1.4.4 Nerve Graft

1.4.5 Others

1.5 Market by Application

1.5.1 Global Nerve Biologic Products Market Size Growth Rate by Application

1.5.2 Direct Nerve Repair/Neurorrhaphy

1.5.3 Nerve Grafting

1.6 Coronavirus Disease 2019 (Covid-19): Nerve Biologic Products Industry Impact

1.6.1 How the Covid-19 is Affecting the Nerve Biologic Products Industry

1.6.1.1 Nerve Biologic Products Business Impact Assessment - Covid-19

1.6.1.2 Supply Chain Challenges

1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products

1.6.2 Market Trends and Nerve Biologic Products Potential Opportunities in the COVID-19 Landscape

1.6.3 Measures / Proposal against Covid-19

1.6.3.1 Government Measures to Combat Covid-19 Impact

1.6.3.2 Proposal for Nerve Biologic Products Players to Combat Covid-19 Impact

1.7 Study Objectives

1.8 Years Considered

2 Executive Summary

2.1 Global Nerve Biologic Products Market Size Estimates and Forecasts

2.1.1 Global Nerve Biologic Products Revenue 2015-2026

2.1.2 Global Nerve Biologic Products Sales 2015-2026

2.2 Nerve Biologic Products Market Size by Region: 2020 Versus 2026

2.2.1 Global Nerve Biologic Products Retrospective Market Scenario in Sales by Region: 2015-2020

2.2.2 Global Nerve Biologic Products Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Nerve Biologic Products Competitor Landscape by Players

3.1 Nerve Biologic Products Sales by Manufacturers

3.1.1 Nerve Biologic Products Sales by Manufacturers (2015-2020)

3.1.2 Nerve Biologic Products Sales Market Share by Manufacturers (2015-2020)

3.2 Nerve Biologic Products Revenue by Manufacturers

3.2.1 Nerve Biologic Products Revenue by Manufacturers (2015-2020)

3.2.2 Nerve Biologic Products Revenue Share by Manufacturers (2015-2020)

3.2.3 Global Nerve Biologic Products Market Concentration Ratio (CR5 and HHI) (2015-2020)

3.2.4 Global Top 10 and Top 5 Companies by Nerve Biologic Products Revenue in 2019

3.2.5 Global Nerve Biologic Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.3 Nerve Biologic Products Price by Manufacturers

3.4 Nerve Biologic Products Manufacturing Base Distribution, Product Types

3.4.1 Nerve Biologic Products Manufacturers Manufacturing Base Distribution, Headquarters

3.4.2 Manufacturers Nerve Biologic Products Product Type

3.4.3 Date of International Manufacturers Enter into Nerve Biologic Products Market

3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

4.1 Global Nerve Biologic Products Market Size by Type (2015-2020)

4.1.1 Global Nerve Biologic Products Sales by Type (2015-2020)

4.1.2 Global Nerve Biologic Products Revenue by Type (2015-2020)

4.1.3 Nerve Biologic Products Average Selling Price (ASP) by Type (2015-2026)

4.2 Global Nerve Biologic Products Market Size Forecast by Type (2021-2026)

4.2.1 Global Nerve Biologic Products Sales Forecast by Type (2021-2026)

4.2.2 Global Nerve Biologic Products Revenue Forecast by Type (2021-2026)

4.2.3 Nerve Biologic Products Average Selling Price (ASP) Forecast by Type (2021-2026)

4.3 Global Nerve Biologic Products Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

5.1 Global Nerve Biologic Products Market Size by Application (2015-2020)

5.1.1 Global Nerve Biologic Products Sales by Application (2015-2020)

5.1.2 Global Nerve Biologic Products Revenue by Application (2015-2020)

5.1.3 Nerve Biologic Products Price by Application (2015-2020)

5.2 Nerve Biologic Products Market Size Forecast by Application (2021-2026)

5.2.1 Global Nerve Biologic Products Sales Forecast by Application (2021-2026)

5.2.2 Global Nerve Biologic Products Revenue Forecast by Application (2021-2026)

5.2.3 Global Nerve Biologic Products Price Forecast by Application (2021-2026)

6 North America

6.1 North America Nerve Biologic Products by Country

6.1.1 North America Nerve Biologic Products Sales by Country

6.1.2 North America Nerve Biologic Products Revenue by Country

6.1.3 U.S.

6.1.4 Canada

6.2 North America Nerve Biologic Products Market Facts & Figures by Type

6.3 North America Nerve Biologic Products Market Facts & Figures by Application

7 Europe

7.1 Europe Nerve Biologic Products by Country

7.1.1 Europe Nerve Biologic Products Sales by Country

7.1.2 Europe Nerve Biologic Products Revenue by Country

7.1.3 Germany

7.1.4 France

7.1.5 U.K.

7.1.6 Italy

7.1.7 Russia

7.2 Europe Nerve Biologic Products Market Facts & Figures by Type

7.3 Europe Nerve Biologic Products Market Facts & Figures by Application

8 Asia Pacific

8.1 Asia Pacific Nerve Biologic Products by Region

8.1.1 Asia Pacific Nerve Biologic Products Sales by Region

8.1.2 Asia Pacific Nerve Biologic Products Revenue by Region

8.1.3 China

8.1.4 Japan

8.1.5 South Korea

8.1.6 India

8.1.7 Australia

8.1.8 Taiwan

8.1.9 Indonesia

8.1.10 Thailand

8.1.11 Malaysia

8.1.12 Philippines

8.1.13 Vietnam

8.2 Asia Pacific Nerve Biologic Products Market Facts & Figures by Type

8.3 Asia Pacific Nerve Biologic Products Market Facts & Figures by Application

9 Latin America

9.1 Latin America Nerve Biologic Products by Country

9.1.1 Latin America Nerve Biologic Products Sales by Country

9.1.2 Latin America Nerve Biologic Products Revenue by Country

9.1.3 Mexico

9.1.4 Brazil

9.1.5 Argentina

9.2 Central & South America Nerve Biologic Products Market Facts & Figures by Type

9.3 Central & South America Nerve Biologic Products Market Facts & Figures by Application

10 Middle East and Africa

10.1 Middle East and Africa Nerve Biologic Products by Country

10.1.1 Middle East and Africa Nerve Biologic Products Sales by Country

10.1.2 Middle East and Africa Nerve Biologic Products Revenue by Country

10.1.3 Turkey

10.1.4 Saudi Arabia

10.1.5 U.A.E

10.2 Middle East and Africa Nerve Biologic Products Market Facts & Figures by Type

10.3 Middle East and Africa Nerve Biologic Products Market Facts & Figures by Application

11 Company Profiles

11.1 Axogen

11.1.1 Axogen Corporation Information

11.1.2 Axogen Description, Business Overview and Total Revenue

11.1.3 Axogen Sales, Revenue and Gross Margin (2015-2020)

11.1.4 Axogen Nerve Biologic Products Products Offered

11.1.5 Axogen Recent Development

11.2 Integra

11.2.1 Integra Corporation Information

11.2.2 Integra Description, Business Overview and Total Revenue

11.2.3 Integra Sales, Revenue and Gross Margin (2015-2020)

11.2.4 Integra Nerve Biologic Products Products Offered

11.2.5 Integra Recent Development

11.3 Synovis

11.3.1 Synovis Corporation Information

11.3.2 Synovis Description, Business Overview and Total Revenue

11.3.3 Synovis Sales, Revenue and Gross Margin (2015-2020)

11.3.4 Synovis Nerve Biologic Products Products Offered

11.3.5 Synovis Recent Development

11.4 Collagen Matrix

11.4.1 Collagen Matrix Corporation Information

11.4.2 Collagen Matrix Description, Business Overview and Total Revenue

11.4.3 Collagen Matrix Sales, Revenue and Gross Margin (2015-2020)

11.4.4 Collagen Matrix Nerve Biologic Products Products Offered

11.4.5 Collagen Matrix Recent Development

11.5 Polyganics

11.5.1 Polyganics Corporation Information

11.5.2 Polyganics Description, Business Overview and Total Revenue

11.5.3 Polyganics Sales, Revenue and Gross Margin (2015-2020)

11.5.4 Polyganics Nerve Biologic Products Products Offered

11.5.5 Polyganics Recent Development

11.6 Checkpoint Surgical

11.6.1 Checkpoint Surgical Corporation Information

11.6.2 Checkpoint Surgical Description, Business Overview and Total Revenue

11.6.3 Checkpoint Surgical Sales, Revenue and Gross Margin (2015-2020)

11.6.4 Checkpoint Surgical Nerve Biologic Products Products Offered

11.6.5 Checkpoint Surgical Recent Development

11.7 Neurotex

11.7.1 Neurotex Corporation Information

11.7.2 Neurotex Description, Business Overview and Total Revenue

11.7.3 Neurotex Sales, Revenue and Gross Margin (2015-2020)

11.7.4 Neurotex Nerve Biologic Products Products Offered

11.7.5 Neurotex Recent Development

11.1 Axogen

11.1.1 Axogen Corporation Information

11.1.2 Axogen Description, Business Overview and Total Revenue

11.1.3 Axogen Sales, Revenue and Gross Margin (2015-2020)

11.1.4 Axogen Nerve Biologic Products Products Offered

11.1.5 Axogen Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

12.1 Nerve Biologic Products Market Estimates and Projections by Region

12.1.1 Global Nerve Biologic Products Sales Forecast by Regions 2021-2026

12.1.2 Global Nerve Biologic Products Revenue Forecast by Regions 2021-2026

12.2 North America Nerve Biologic Products Market Size Forecast (2021-2026)

12.2.1 North America: Nerve Biologic Products Sales Forecast (2021-2026)

12.2.2 North America: Nerve Biologic Products Revenue Forecast (2021-2026)

12.2.3 North America: Nerve Biologic Products Market Size Forecast by Country (2021-2026)

12.3 Europe Nerve Biologic Products Market Size Forecast (2021-2026)

12.3.1 Europe: Nerve Biologic Products Sales Forecast (2021-2026)

12.3.2 Europe: Nerve Biologic Products Revenue Forecast (2021-2026)

12.3.3 Europe: Nerve Biologic Products Market Size Forecast by Country (2021-2026)

12.4 Asia Pacific Nerve Biologic Products Market Size Forecast (2021-2026)

12.4.1 Asia Pacific: Nerve Biologic Products Sales Forecast (2021-2026)

12.4.2 Asia Pacific: Nerve Biologic Products Revenue Forecast (2021-2026)

12.4.3 Asia Pacific: Nerve Biologic Products Market Size Forecast by Region (2021-2026)

12.5 Latin America Nerve Biologic Products Market Size Forecast (2021-2026)

12.5.1 Latin America: Nerve Biologic Products Sales Forecast (2021-2026)

12.5.2 Latin America: Nerve Biologic Products Revenue Forecast (2021-2026)

12.5.3 Latin America: Nerve Biologic Products Market Size Forecast by Country (2021-2026)

12.6 Middle East and Africa Nerve Biologic Products Market Size Forecast (2021-2026)

12.6.1 Middle East and Africa: Nerve Biologic Products Sales Forecast (2021-2026)

12.6.2 Middle East and Africa: Nerve Biologic Products Revenue Forecast (2021-2026)

12.6.3 Middle East and Africa: Nerve Biologic Products Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

13.1 Market Opportunities and Drivers

13.2 Market Challenges

13.3 Market Risks/Restraints

13.4 Porter’s Five Forces Analysis

13.5 Primary Interviews with Key Nerve Biologic Products Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

14.1 Value Chain Analysis

14.2 Nerve Biologic Products Customers

14.3 Sales Channels Analysis

14.3.1 Sales Channels

14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.2 Data Source

16.2 Author Details